# Rezurock

NDC: 79802-200
Generic name: belumosudil
Labeler / Manufacturer: Kadmon Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210716

FDA application: NDA214783

## Active ingredients

- BELUMOSUDIL: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"79802-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=79802-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=102e4ef4-7f84-4e34-8df1-479c24d1575d